Organoids, 3D Cell Culture, and Advanced Stem Cell Models
Advanced stem cell models have transformed biomedical research by providing more accurate systems for studying human development, diseases, and therapeutic responses. This area focuses on organoids, three-dimensional cell cultures, and innovative laboratory models developed using stem cells. Researchers will discuss how these technologies replicate human tissues and improve disease understanding. The topic highlights applications of organoids in drug discovery, personalized medicine, and regenerative research. Experts will explore improvements in culture techniques, scalability, and biological accuracy. Discussions will address the potential of advanced models to reduce dependence on traditional experimental approaches. This area provides insights into the future of human disease modeling and precision healthcare.
- Organoid development and applications
- Three-dimensional stem cell culture systems
- Tissue-specific organoid models
Related Conference of Organoids, 3D Cell Culture, and Advanced Stem Cell Models
19th International Conference on Human Genomics and Genomic Medicine
22nd World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research
17th International Conference on Human Genetics and Genetic Diseases
Organoids, 3D Cell Culture, and Advanced Stem Cell Models Conference Speakers
Recommended Sessions
- Adult Stem Cells and Tissue-Specific Stem Cells
- Artificial Intelligence, Bioinformatics, and Stem Cell Research
- Cancer Stem Cells and Oncology Applications
- Embryonic Stem Cells and Induced Pluripotent Stem Cells
- Future Perspectives and Innovations in Stem Cell Research
- Gene Editing and Stem Cell Engineering
- Organoids, 3D Cell Culture, and Advanced Stem Cell Models
- Regenerative Medicine and Tissue Engineering
- Stem Cell Applications in Diabetes and Metabolic Disorders
- Stem Cell Applications in Immunology and Immune Therapies
- Stem Cell Applications in Wound Healing and Skin Regeneration
- Stem Cell Biology and Fundamental Research
- Stem Cell Ethics, Regulations, and Clinical Translation
- Stem Cell Manufacturing and Bioprocessing Technologies
- Stem Cell-Based Drug Discovery and Disease Modeling
- Stem Cell-Based Therapies and Clinical Applications
- Stem Cells in Cardiovascular Regeneration
- Stem Cells in Neurological Disorders and Brain Repair
- Stem Cells in Ophthalmology and Vision Restoration
- Stem Cells in Orthopedics and Musculoskeletal Regeneration
Related Journals
Are you interested in
- Achieving efficient delivery and editing - CRISPR 2026 (UAE)
- Advanced Imaging and Single-Cell Technologies - cellscience-cs-2027 (UK)
- Animal Genetics - Genome 2027 (Germany)
- Artificial Intelligence in Cell and Molecular Research - cellscience-cs-2027 (UK)
- Bioinformatics and Computational Biology - cellscience-cs-2027 (UK)
- Bioinformatics and Computational Biology - Genome 2027 (Germany)
- Biomarkers and Microarrays - Genome 2027 (Germany)
- Biotechnology and Molecular Therapeutics - cellscience-cs-2027 (UK)
- Cancer and stem cells - CRISPR 2026 (UAE)
- Cancer Cell Biology and Molecular Oncology - cellscience-cs-2027 (UK)
- Cancer Genomics - Genome 2027 (Germany)
- Cell Biology and Cellular Mechanisms - cellscience-cs-2027 (UK)
- Cellular Metabolism and Metabolic Biology - cellscience-cs-2027 (UK)
- Cellular signaling and Signal Transduction - cellscience-cs-2027 (UK)
- Clinical genomics - Genome 2027 (Germany)
- Comparative Genomics - Genome 2027 (Germany)
- CRISPR technologies and society - CRISPR 2026 (UAE)
- CRISPR technologies beyond genome editing and gene regulation - CRISPR 2026 (UAE)
- Emerging Technologies and Future Directions in Cell Science - cellscience-cs-2027 (UK)
- Epigenomics and Epigenetics - Genome 2027 (Germany)
- Functional Genomics - Genome 2027 (Germany)
- Gene Editing and Genetic Engineering - Genome 2027 (Germany)
- Genetic Disorder - Genome 2027 (Germany)
- Genetics, Genomics and Genome Biology - cellscience-cs-2027 (UK)
- Genome editing and gene regulation in human health - CRISPR 2026 (UAE)
- Genome editing and gene regulation in industrial bacterial biotechnology - CRISPR 2026 (UAE)
- Genome editing and gene regulation in industrial eukaryotic biotechnology - CRISPR 2026 (UAE)
- Genome Editing Methods and Novel Tools - CRISPR 2026 (UAE)
- Genomic Instability - Genome 2027 (Germany)
- Genomic Medicine - Genome 2027 (Germany)
- Horizons of CRISPR biology - CRISPR 2026 (UAE)
- Immunology and Cellular Immunity - cellscience-cs-2027 (UK)
- Microbial Genomics - Genome 2027 (Germany)
- Molecular Biology and Gene Regulation - cellscience-cs-2027 (UK)
- Molecular Diagnostics and Biomarkers - cellscience-cs-2027 (UK)
- Molecular Medicine and Translational Research - cellscience-cs-2027 (UK)
- Molecular Microbiology and Host–Pathogen Interactions - cellscience-cs-2027 (UK)
- Next generation sequencing - Genome 2027 (Germany)
- Nutrigenomics - Genome 2027 (Germany)
- Personalized and Regenerative Medicine - Genome 2027 (Germany)
- Pharmacogenomics - Genome 2027 (Germany)
- Plant and Animal Biotechnology - CRISPR 2026 (UAE)
- Plant Genomics and Molecular Pharming - Genome 2027 (Germany)
- Stem Cell Biology and Regenerative Medicine - cellscience-cs-2027 (UK)
- Structural Biology and Bioinformatics - CRISPR 2026 (UAE)
- Structural Genomics - Genome 2027 (Germany)
- Therapeutic Genome Editing - CRISPR 2026 (UAE)
- Trends in Genomics and Pharmacogenomics - Genome 2027 (Germany)
